Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 1,918	$ 170
Trade accounts and other receivables (net of allowance of $6 at June 30, 2017 and $6 at December 31, 2016)	693	938
Inventories	150	138
Assets held for sale (Note 3)	1,004	24
Other current assets and deferred charges	204	192
Total current assets	3,969	1,462
Investments	6,675	6,701
Property, plant, and equipment, at cost	38,898	38,912
Accumulated depreciation and amortization	(10,856)	(10,484)
Property, plant, and equipment – net	28,042	28,428
Intangible assets – net of accumulated amortization	9,481	9,663
Regulatory assets, deferred charges, and other	603	581
Total assets	48,770	46,835
Current liabilities:
Accounts payable	734	623
Liabilities held for sale (Note 3)	36	0
Accrued liabilities	1,275	1,448
Commercial paper	0	93
Long-term debt due within one year	1,951	785
Total current liabilities	3,996	2,949
Long-term debt	21,325	22,624
Deferred income tax liabilities	5,200	4,238
Regulatory liabilities, deferred income, and other	3,068	2,978
Contingent liabilities (Note 12)
Stockholders’ equity:
Common stock (960 million shares authorized at $1 par value; 861 million shares issued at June 30, 2017 and 785 million shares issued at December 31, 2016)	861	785
Capital in excess of par value	18,471	14,887
Retained deficit	(9,654)	(9,649)
Accumulated other comprehensive income (loss)	(331)	(339)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	8,306	4,643
Noncontrolling interests in consolidated subsidiaries	6,875	9,403
Total equity	15,181	14,046
Total liabilities and equity	$ 48,770	$ 46,835